IL76121A0 - Protein absorption enhancing agents - Google Patents

Protein absorption enhancing agents

Info

Publication number
IL76121A0
IL76121A0 IL76121A IL7612185A IL76121A0 IL 76121 A0 IL76121 A0 IL 76121A0 IL 76121 A IL76121 A IL 76121A IL 7612185 A IL7612185 A IL 7612185A IL 76121 A0 IL76121 A0 IL 76121A0
Authority
IL
Israel
Prior art keywords
absorption enhancing
enhancing agents
protein absorption
protein
preferably hydroxylamine
Prior art date
Application number
IL76121A
Other languages
English (en)
Original Assignee
Survival Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/638,695 external-priority patent/US4658830A/en
Priority claimed from US06/708,845 external-priority patent/US4661469A/en
Application filed by Survival Technology filed Critical Survival Technology
Publication of IL76121A0 publication Critical patent/IL76121A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/19Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL76121A 1984-08-08 1985-08-18 Protein absorption enhancing agents IL76121A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/638,695 US4658830A (en) 1984-08-08 1984-08-08 Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
US06/708,845 US4661469A (en) 1984-08-08 1985-03-06 t-PA composition capable of being absorbed into the blood stream and method of administration
US71670585A 1985-03-27 1985-03-27

Publications (1)

Publication Number Publication Date
IL76121A0 true IL76121A0 (en) 1985-12-31

Family

ID=27417624

Family Applications (1)

Application Number Title Priority Date Filing Date
IL76121A IL76121A0 (en) 1984-08-08 1985-08-18 Protein absorption enhancing agents

Country Status (7)

Country Link
EP (1) EP0191814B1 (xx)
AT (1) ATE81983T1 (xx)
AU (1) AU591069B2 (xx)
CA (1) CA1264030A (xx)
DE (1) DE3586795T2 (xx)
IL (1) IL76121A0 (xx)
WO (1) WO1986001109A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US4305947A (en) * 1980-08-26 1981-12-15 Survival Technology, Inc. Stable aqueous solutions of pralidoxime salts
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
EP0201153A3 (en) * 1985-02-09 1987-10-07 Beecham Group Plc Modified enzyme and process for its preparation

Also Published As

Publication number Publication date
DE3586795D1 (de) 1992-12-10
DE3586795T2 (de) 1993-05-19
EP0191814A4 (en) 1987-03-16
AU591069B2 (en) 1989-11-30
EP0191814B1 (en) 1992-11-04
EP0191814A1 (en) 1986-08-27
AU4721185A (en) 1986-03-07
CA1264030A (en) 1989-12-27
ATE81983T1 (de) 1992-11-15
WO1986001109A1 (en) 1986-02-27

Similar Documents

Publication Publication Date Title
IL76119A (en) Device for initiating reperfusion treatment when heart attack symptoms are present
EP0191056A4 (en) T-PA COMPOSITION AND METHOD FOR ITS INCORPORATION INTO THE BLOOD FLOW.
DE3687741D1 (de) Geraet zur ultraschallechographie der bewegung von koerperorganen, insbesondere der blutstroemung oder des herzens.
DE3685625D1 (de) Antikoerperkomplexe von haptenmodifizierten diagnostischen oder therapeutischen mitteln.
NO943473D0 (no) "Freezer"-stykke med hudens pH, og fremgangsmåte for dets fremstilling
EA199800946A1 (ru) Концентрированный препарат антител
DK0416678T3 (da) Topiske præparater indeholdende Defibrotid
DK504389A (da) Adjuveret antigenoploesning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved
DK325289D0 (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
GR3001862T3 (en) Pharmaceutical preparation for tinea pedis
HUT41632A (en) Process for preparing agents for the enhancement of protein absorption
IL76121A0 (en) Protein absorption enhancing agents
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
ATE79550T1 (de) Die proteinabsorption verbessernde stoffe.
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
NO864742D0 (no) Dna-sekvens som koder for human vevsplasminogenaktivator, rekombinant dna-sekvens, vertcelle transformert med denne samt fremgangsmaate for fremstilling av plasminogenaktivatoren.
IT8763326V0 (it) Presidio medico per l'elettromagnetoterapia.
DK158985D0 (da) Konjugat af et protein med et cytotoksisk middel, fremgangsmaade til dets fremstilling og anvendelse heraf i reagenssaet til tumorbehandlingeller -analyse
IT8804860A0 (it) Procedimento per il recupero di calore, con eventuale recupero od uso dell'umidita', ceduto direttamente o indirettamente dal corpo umano e dispositivo per la sua attuazione.
IT216890Z2 (it) Astuccio provvisto di sedi longitudinali per l'alloggiamento corretto e sicuro di una forbicina, una pinzettaed una limetta, per manicure.
KR870700020A (ko) 단백질 흡수증가제
IT8819879A0 (it) Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.
IT8421572V0 (it) Presidio medico per l'educazione fisiologica.
IT8420529A0 (it) N-acetil-s-acil-cisteina adattivita' terapeutica, procedimento per loro preparazione e loro uso in terapia.